New perspectives in the treatment of age-related macular degeneration;Neue Entwicklungen in der Therapie der altersabhängigen Makuladegeneration

Deutsches Arzteblatt

Volumn 103, Issue 8, 2006, Pages

  Holz, Frank G ^a   Binderwald Willich, Almut ^a   Schmitz Valckenberg, Steffen ^a   Eter, Nicole ^a   Scholl, Hendrik P N ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Age related macular degeneration; Cortico steroid; Macular surgery; Therapeutic concept; VEGF

Indexed keywords

ALPHA2A INTERFERON; BEVACIZUMAB; CORTICOSTEROID; PEGAPTANIB; RANIBIZUMAB; THALIDOMIDE; VASCULOTROPIN ANTIBODY;

ARTICLE; BLINDNESS; CLINICAL FEATURE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DEVELOPED COUNTRY; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; EXCISION; GERMANY; HEAT TREATMENT; HUMAN; INCIDENCE; LASER SURGERY; MEMBRANE PERMEABILITY; MICROSURGERY; MOLECULAR MECHANICS; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PREVALENCE; READING; REGISTRATION; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA TRANSLOCATION; SUBRETINAL NEOVASCULARIZATION; SURGICAL TECHNIQUE; VISUAL IMPAIRMENT;

EID: 34247551007     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Holz FG, Pauleikhoff D, Spaide RF, Bird AC, eds.: Age-related macular degeneration. Berlin, Heidelberg, New York: Springer-Verlag 2004.
2. Hyman LG, Lilienfeld AM, Ferris FL, Fine SL: Senile macular degeneration: a case control study. Am J Epidemiol 1983; 118: 213-27.
3. Klaver CCW, van Leeuwen R, Vingerling JR, De Jong PTVM: Epidemiology of age-related maculopathy. In: Holz FG, Pauleikhoff D, Spaide RF, Bird AC, Hrsg: Age-related macular degeneration. Berlin, Heidelberg, New York: Springer-Verlag 2004; 1-22.
4. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH: Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 2002; 109: 1767-79.
5. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP: Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003; 48: 257-93.
6. Pauleikhoff D, Bornfeld N, Gabel V-P, Holz FG, Roider H: Konsenspapier der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft und des Berufsverbandes der Augenärzte - Stellungnahme zur aktuellen Therapie der neovaskulären AMD. Klin Monatsbl Augenheilkd 2005; 222: 381-8.
7. Scholl HP, Weber BH, Noethen MM, Wienker T, Holz FG: Y402H polymorphism in complement factor H and age-related macular degeneration (AMD). Ophthalmologe 2005; 102: 1029-35.
8. Klein RJ, Zeiss C, Chew EY et al.: Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-9.
9. Holz FG, Pauleikhoff D, Klein R, Bird AC: Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004; 137: 504-10.
10. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
11. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE: Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 2000; 157: 135-44.
12. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group: Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004; 351: 2805-16.
13. Ciulla TA, Criswell MH, Danis RP, Hill TE: Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001; 119: 399-404.
14. Jonas JB: Intravitreal injection of triamcinolone acetonide. In: Holz FG, Spaide RF, Hrsg.: Medical Retina. Berlin, Heidelberg, New York: Springer-Verlag 2005; 143-64.
15. Hawkins BS, Bressler NM, Miskala PH et al., Submacular Surgery Trials (SST) Research Group: Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology 2004; 111: 1967-80.
16. Machemer R, Steinhorst UH: Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefe's Arch Clin Exp Ophthalmol 1993; 231: 635-41.
17. Abdel-Meguid A, Lappas A, Hartmann K et al.: One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 2003; 87: 615-21.
18. Aisenbrey S, Lafaut BA, Szurman P et al.: Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 2002; 120: 451-9.
19. Algvere PV, Gouras P, Dafgard Kopp E: Long-term outcome allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol 1999; 9: 217-30.
20. Thumann G, Kirchhof B: Transplantation von Irispigmentepithel. Ophthalmologe 2004; 101: 882-5.
21. Stanga PE, Kychenthal A, Fitzke FW et al.: Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology 2002; 109: 1492-8.
22. Kirchhof B, Heussen FA, Llacer H, Loussen AM: Peripheral autologous translocation of the choroid in age related macular degeneration (PATCH) in 50 eyes. ARVO 2005; e-abstract #3623.
23. Van Meurs JC, van den Biesen PR: Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol 2003; 136: 688-95.
24. Bindewald A, Roth F, Van Meurs J, Holz FG: Transplantation von retinalem Pigmentepithel (RPE) nach CNV-Exzision bei altersabhängiger Makuladegeneration. Ophthalmologe 2004; 101: 886-94.
25. Holz FG, Bindewald A, Schutt F, Specht H: Microablation of choroidal tissue by a 308 nm AIDA Excimer laser for RPE transplantaion in patients with age-related macular degeneration. Biomed Tech 2003; 48: 82-5.